A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC]
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Enriqueta Felip, PR
Hospital Universitari Vall d'Hebron, Barcelone, Spain
Principal InvestigatorKOL profile → - Jaafar Bennouma, MD
Institut de Cancérologie de l'Ouest- Institut René Gauduchau, Nantes, France
Principal Investigator - Jean-Pierre Delord, PR
Institut Claudius Regaud, Toulouse, France
Principal Investigator - Jèrôme Fayette, MD
Centre Léon Bérard, Lyon, France
Principal Investigator - Luis Paz-Ares, PR
Hospital Universitario Virgen del Rocío, Seville, Spain
Principal InvestigatorKOL profile → - Mariano Provencio, PR
Hospital Puerta de Hierro Majadahonda, Madrid, Spain
Principal Investigator - Nicolas Isambert, MD
Centre GF Leclerc, Dijon, France
Principal Investigator - Ruth Plummer, PR
Freeman Hospital, Newcastle, UK
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Gf Leclerc
Dijon, France
- Centre Léon Bérard
Lyon, France
- Institut de Cancérologie de L'Ouest- Institut René Gauduchau
Nantes, France
- Institut Claudius Regaud
Toulouse, France
- Hospital Universitari Vall D'Hebron
Barcelona, Spain
- Hospital Puerta de Hierro Majadahonda
Madrid, Spain
- Hospital Universitario Virgen del Rocío
Seville, Spain
- Freeman Hospital
Newcastle, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2012
- Primary completion
- 30 Nov 2014
- Completion
- 30 Nov 2014
- Last update posted
- 8 Apr 2015
- Registered enrollment
- 82
- Registry id
- NCT01714037
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.